Pharmacokinetics of tuberculosis drugs in HIV-infected patients from Irkutsk, Russian Federation: redefining drug activity

Galina Lyles, Oleg Ogarkov, Svetlana Zhdanova, Charles A. Peloquin, Andrew Ebers, Herman Pfaeffle, Mohammad H. Al-Shaer, Elena Moiseeva, Elena Zorkaltseva, Mikhail Koscheev, Eric R. Houpt, Scott K. Heysell

Source: Eur Respir J, 51 (5) 1800109; 10.1183/13993003.00109-2018
Journal Issue: May
Disease area: Respiratory infections

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Galina Lyles, Oleg Ogarkov, Svetlana Zhdanova, Charles A. Peloquin, Andrew Ebers, Herman Pfaeffle, Mohammad H. Al-Shaer, Elena Moiseeva, Elena Zorkaltseva, Mikhail Koscheev, Eric R. Houpt, Scott K. Heysell. Pharmacokinetics of tuberculosis drugs in HIV-infected patients from Irkutsk, Russian Federation: redefining drug activity. Eur Respir J, 51 (5) 1800109; 10.1183/13993003.00109-2018

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Treatment outcomes of the use of moxifloxacin in management of patients with XDR-TB in Tomsk Oblast of the Russian Federation
Source: Annual Congress 2008 - Multidrug-resistant and the emerging threat of extensively drug-resistant tuberculosis
Year: 2008



Effectiveness of national standardized and WHO regimens and risk factors of unfavorable outcomes in treatment of patients with MDR-TB in Novosibirsk Oblast, Russian Federation
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1
Year: 2014


Tuberculosis treatment outcomes in HIV co-infected patients in Novokuznetsk, Russian Federation
Source: International Congress 2018 – Tuberculosis comorbidities
Year: 2018


Extensively drug-resistant tuberculosis in the penitentiary facilities of the Russian Federation
Source: International Congress 2018 – Drug-resistant tuberculosis
Year: 2018




Multidrug-resistance tuberculosis and HIV-infected patients, the effectiveness of the treatment in Ukraine
Source: Annual Congress 2010 - Tuberculosis drug resistance
Year: 2010


Drug resistance of Mycobacterium tuberculosis in the Ural region of Russian Federation
Source: International Congress 2019 – Tuberculosis: from diagnosis to complications
Year: 2019

Tuberculosis prophylaxis in HIV patients in Tomsk penitentiary system, Russia
Source: Annual Congress 2008 - COPD and miscellaneous
Year: 2008

Psychiatric disorders in MDR TB patients on the treatment regimens under DOTS-plus programme in Tomsk oblast penitentiary system
Source: Eur Respir J 2001; 18: Suppl. 33, 513s
Year: 2001

Clinical profile of drug resistant tuberculosis in Pediatric Population, India.
Source: International Congress 2017 – Paediatric TB: MDRTB (II)
Year: 2017


Dynamics analysis of MBT drug resistance to antitubercolosis second-line drugs (Saratov region hospital, Russia)
Source: International Congress 2016 – Update on drug-resistant tuberculosis
Year: 2016

Tuberculosis treatment completion in migrants, St.-Petersburg, Russian Federation
Source: Annual Congress 2011 - Tuberculosis epidemiology and public health
Year: 2011

The risk of default in TB patients in the Russian Federation
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2
Year: 2014

Improving adherence in TB patients with alcohol and drug dependence through Sputnik initiative in Tomsk, Russia
Source: Annual Congress 2008 - Epidemiological and clinical aspects of tuberculosis control
Year: 2008


The distribution of Beijing genotype among mycobacterium tuberculosis strains obtained from patients of different dispensary registration groups from Nizhny Novgorod region of the Russian Federation in 2013-2014
Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology
Year: 2015

Particularities of a cohort of preXDR / XDR TB patients treated with group 5 medication, hospitalized in MDR TB Department Institute of Pneumophtisiology Bucharest, Romania
Source: International Congress 2016 – Update on drug-resistant tuberculosis
Year: 2016


New approaches to treatment of HIV-associated tuberculosis in penitentiary institutions of Belarus
Source: Eur Respir J 2004; 24: Suppl. 48, 651s
Year: 2004

Drug resistant tuberculosis in Odessa, Southern Ukraine: Beijing family strains prevalence and the role of prisons in drug resistant TB transmission
Source: Eur Respir J 2006; 28: Suppl. 50, 290s
Year: 2006

Dynamics of MBT drug resistance in Saratov Region Hospital, Russia
Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis
Year: 2016

Primary drug resistance in HIV/tuberculosis patients in two large cities of Siberia
Source: International Congress 2016 – Non-tuberculous mycobacteria: HIV-TB co-infection and adenosine deaminase (ADA)
Year: 2016

Characteristics of HIV-positive and HIV-negative new tuberculosis cases in Moscow, Russia
Source: International Congress 2016 – Non-tuberculous mycobacteria: HIV-TB co-infection and adenosine deaminase (ADA)
Year: 2016